Ann: Quarterly Report for period ending 30 June 2019, page-2

Every quarter we are spending as much on "administration" as we are the NIRP development. That for me is already a problem. I assume "administration" includes salaries as "staff costs" are zero. Can anybody clarify that for me? If the directors were serious about this technology, the company would be spending more on the tech than administration/salaries. It's like a small biotech spending more on administration that R&D.. aka a lifestyle company.

Cash on hand will get us through 2 more quarters. Basically we have to finish and produce the test samples or it's all over, I don't think any more funding would be forthcoming. No mention of the attempted removal of TC